Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

November 1, 2023

Study Completion Date

January 1, 2024

Conditions
Diabetic RetinopathyVitreomacular Traction
Interventions
DRUG

Methotrexate 25 MG/ML

Methotrexate is a folate derivative that inhibits several enzymes responsible for nucleotide synthesis. This inhibition leads to suppression of inflammation as well as prevention of cell division.

PROCEDURE

parsplana vitrectomy

Pars plana vitrectomy (PPV) is a technique in vitreoretinal surgery that enables access to the posterior segment for treating tractional retinal detachment in advanced proliferative diabetic retinopathy, in a controlled, closed system.

Trial Locations (1)

61519

ophthalmology department, Minia university hospital, Minya

All Listed Sponsors
lead

Minia University

OTHER